Mohammed Karim

Chief, Division of Hematology/Immunology/Transfusion, at Sidra Medicine and Clinical Professor in Immunopathology, Qatar University. Yousuf studied medicine at Cambridge University and Guy’s & St Thomas’ Hospitals, qualifying in 1993 with Distinctions in Medicine and Pathology. He was Consultant Immunologist at Surrey Pathology Services 2004-18 and Clinical Lead in Immunology at Guy’s & St Thomas’ Hospitals, London 2006-14.

He was previously Chair of the Clinical Immunology Committee of the British Society for Allergy and Clinical Immunology, and is currently Country Advisor for Qatar for the Royal College of Pathologists. He is Steering Committee Chair for the “BASICS” project developing international recommendations for hypogammaglobulinemia secondary to B-cell therapies. He is co-Lead of the Sidra Immune Dysregulation Clinical Research Program. He has authored 100 publications and chapters, and received grant awards totaling $3.7 million.

4 August, 2026

Sidra Medicine Launches Women’s Private Home Visits: Midwifery Care Program

Sidra Medicine, a member of Qatar Foundation, has launched its Women's Private Home Visits: Midwifery Care program, a new private service that extends expert postnatal care beyond the hospital.

Sidra Medicine Administers Qatar’s First Itvisma<sup>TM</sup> Gene Therapy for Spinal Muscular Atrophy

28 July, 2026

Sidra Medicine Administers Qatar’s First Itvisma^TM Gene Therapy for Spinal Muscular Atrophy

One-time gene replacement therapy expands access to precision treatment for eligible children, adolescents, and adults living with spinal muscular atrophy Doha, Qatar – 28 July 2026: Sidra Medicine, a member

21 July, 2026

Sidra Medicine Advances Precision Nutrition Research to Improve Maternal and Child Health

Sidra Medicine, a member of Qatar Foundation, is advancing the future of maternal and child healthcare through groundbreaking research in precision nutrition.

1 July, 2026

Sidra Medicine Honors Class of 2026 and Expands the Next Generation of Healthcare Leaders

Sidra Medicine, a member of Qatar Foundation, celebrated the achievements of the Class of 2026 during a graduation ceremony on 30 June 2026 to mark its fourth Medical Education Day.

27 June, 2026

Sidra Medicine Launches Specialized Microbiome Service to Advance Precision Care for Women and Children

New service complements upcoming MENA Microbiome Conference 2026, reinforcing Qatar's leadership in microbiome science and translational research

24 June, 2026

Sidra Medicine Expands Medical Education Pathways Through Observership and Future Doctor Programs

Sidra Medicine ,a member of Qatar Foundation, is expanding its investment in healthcare workforce development through the introduction of its Medical Observership Program and the continued success of its Future Doctor Program.

16 June, 2026

Sidra Medicine Publishes Groundbreaking Report on Novel Treatment for Rare Pediatric Obesity Case

A case report by Sidra Medicine, a member of Qatar Foundation, has been published in Frontiers in Endocrinology detailing the successful treatment of severe acquired hypothalamic obesity (aHO) in a young child.

10 June, 2026

Sidra Medicine Achieves ANCC Pathway to Excellence Designation with Distinction

Sidra Medicine, a member of Qatar Foundation, has become the first hospital in Qatar to achieve the prestigious American Nurses Credentialing Center (ANCC) Pathway to Excellence designation with distinction.

2 June, 2026

Sidra Medicine and Zulal Wellness Resort by Chiva-Som Sign MoU to Elevate Wellness Programs

Sidra Medicine and Zulal Wellness Resort by Chiva-Som, members of Qatar Foundation, officially signed a Memorandum of Understanding (MoU) to collaborate on the development of integrated wellness and preventive health programs.